Skip to main content

Table 1 Patients' characteristics

From: Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study

Characteristics Case control cohorts
  Patients surviving Patients surviving
  > 18 months (n = 40) ≤ 18 months (n = 40)
  (2000-2005) (2000-2005)
Age (years)   
< 50 12(30%) 9 (23%)
50 28(70%) 31(77%)
Gender   
Male 24(60%) 24(60%)
Female 16(40%) 16(40%)
RPA class   
III-IV 28(70%)* 10(25%)*
V-VI 12(30%) 30(75%)
Extent of surgery   
Partial 3 (7.5%) 9 (22.5%)
Radical 37(92.5%)# 31(77.5%)#
Gammaknife   
No 28(70%) 35(87.5%)
Yes 12(30%) 5 (12.5%)
RT + Temozolomide   
No 32(80%) 39(97%)
yes 8 (2%) 1 (3%)
RT + adjuvant chemotherapy   
No 17(42%) 21(52%)
Yes 23(58%) 19(48%)
Median follow-up time of those alive at study closure (months) 48 (n = 15) 0 (n = 0)
  1. A significant association was observed between RPA III-VI and number of patients with overall survival > 18 months *: p < .0001. No significant association was observed between radical surgery and longer patients survival #: p .06 (Chi-Square test)